https://www.selleckchem.com/products/gdc-0994.html
A decrease in the blood flow below a current level in the brain results in ischemia. Studies demonstrated that human trophoblast progenitor cells (hTPCs) contribute to the treatment of many diseases. Therefore, hTPCs might be a promising source to repair ischemia in cerebral ischemia models. For this purpose, we evaluated the expression of many neurogenesis markers by performing hTPC transplantation after focal cerebral ischemia in rats. hTPCs, isolated from the term placentae, were characterized by immunofluorescent staining and diffe
Like
Comment
Share
